https://www.selleckchem.com/pr....oducts/Gefitinib.htm
0±0.6g/dl before, 3.9±0.8g/dl after; p less then 0.05). The most common complication was occlusion (30%). Relative risk of complications increased significantly when shunt placement was more than 70 days after surgery and in patients receiving more than 5 paracenteses before PVS placement (AR 0.71% vs 0.25%, RR 2.9, p less then 0.048 and AR 0.6% vs 0.125%, RR 4.8, p less then 0.04, respectively). CONCLUSION PVS permanently treated CA in 90% of patients after RPLND. PVS was removed in 85% of patients. Shunt placement is an effective an
Like
Comment
Share
